- Wednesday, May 3, 2023
8:00 AM – 8:15 AM ET
Welcome and Introduction
8:00 AM – 8:15 AM ET
Welcome and IntroductionTime Zone: ETCo-Chair: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Co-Chair###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Co-Chair: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### 8:15 AM – 8:50 AM ET
Session 1: Updates in Rare Ovarian Cancers (Low Grade, Non-Serous Epithelial and Non-Epithelial)
8:15 AM – 8:50 AM ET
Session 1: Updates in Rare Ovarian Cancers (Low Grade, Non-Serous Epithelial and Non-Epithelial)Time Zone: ETPresenter: – Levine Cancer Institute at Atrium Health
Wake Forest University School of Medicine
Jubilee Brown, MD (she/her/hers) – Levine Cancer Institute at Atrium Health
Wake Forest University School of Medicine ### 1862807###Presenter###Professor and Division Director of Gynecologic Oncology###Levine Cancer Institute at Atrium Health
Wake Forest University School of Medicine###Presenter: – Levine Cancer Institute at Atrium Health
Wake Forest University School of Medicine
### she/her/hers8:50 AM – 9:00 AM ET
Live Q&A
8:50 AM – 9:00 AM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter: – Levine Cancer Institute at Atrium Health
Wake Forest University School of Medicine
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Jubilee Brown, MD (she/her/hers) – Levine Cancer Institute at Atrium Health
Wake Forest University School of Medicine ### 1862807###Presenter###Professor and Division Director of Gynecologic Oncology###Levine Cancer Institute at Atrium Health
Wake Forest University School of Medicine###Presenter: – Levine Cancer Institute at Atrium Health
Wake Forest University School of Medicine
### she/her/hers9:00 AM – 9:15 AM ET
Break
9:00 AM – 9:15 AM ET
Break
Time Zone: ET
9:15 AM – 9:50 AM ET
Session 2: Management of Metastatic/Recurrent Cervical Cancer in the Front Line
9:15 AM – 9:50 AM ET
Session 2: Management of Metastatic/Recurrent Cervical Cancer in the Front LineTime Zone: ETPresenter: – University of California, Irvine
Krishnansu S. Tewari, MD (he/him/his) – University of California, Irvine ### 1928325###Presenter###Professor, Division Director, Gynecologic Oncologist###University of California, Irvine###Presenter: – University of California, Irvine
### he/him/his9:50 AM – 10:00 AM ET
Live Q&A
9:50 AM – 10:00 AM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Speaker: – University of California, Irvine
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Krishnansu S. Tewari, MD (he/him/his) – University of California, Irvine ### 1928325###Speaker###Professor, Division Director, Gynecologic Oncologist###University of California, Irvine###Speaker: – University of California, Irvine
### he/him/his10:00 AM – 10:15 AM ET
Break
10:00 AM – 10:15 AM ET
Break
Time Zone: ET
10:15 AM – 11:15 AM ET
Professor of medicine in the Division of Hematology, Oncology, and Cell Therapy
10:15 AM – 11:15 AM ET
Non-CME Innovation Theater
Time Zone: ET
11:15 AM – 11:35 AM ET
Break
11:15 AM – 11:35 AM ET
Break
Time Zone: ET
11:35 AM – 11:55 AM ET
Session 3: Care of Special Populations
11:35 AM – 11:55 AM ET
Session 3: Care of Special PopulationsPresenter: – Cedars-Sinai Medical Center
BJ Rimel, MD – Cedars-Sinai Medical Center ### 1538157###Presenter###Associate Professor###Cedars-Sinai Medical Center###Presenter: – Cedars-Sinai Medical Center
### 11:55 AM – 12:10 PM ET
Live Q&A
11:55 AM – 12:10 PM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Speaker: – Cedars-Sinai Medical Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ BJ Rimel, MD – Cedars-Sinai Medical Center ### 1538157###Speaker###Associate Professor###Cedars-Sinai Medical Center###Speaker: – Cedars-Sinai Medical Center
### 12:10 PM – 12:30 PM ET
Break
12:10 PM – 12:30 PM ET
Break
Time Zone: ET
12:30 PM – 1:15 PM ET
Session 4: Assessment and Intervention for Chemotherapy-Induced Neuropathy and Myopathy
12:30 PM – 1:15 PM ET
Session 4: Assessment and Intervention for Chemotherapy-Induced Neuropathy and MyopathyPresenter: – The University of Oklahoma Health Sciences Center/ OU Health Stephenson Cancer Center
Elizabeth Hile, PT, PhD (she/her/hers) – The University of Oklahoma Health Sciences Center/ OU Health Stephenson Cancer Center ### 1862413###Presenter###Associate Professor/ Director of Cancer Rehabilitation Research & Laboratory###The University of Oklahoma Health Sciences Center/ OU Health Stephenson Cancer Center###Presenter: – The University of Oklahoma Health Sciences Center/ OU Health Stephenson Cancer Center
### she/her/hers1:15 PM – 1:30 PM ET
Break
1:15 PM – 1:30 PM ET
Break
Time Zone: ET
1:30 PM – 2:30 PM ET
Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings
1:30 PM – 2:30 PM ET
Non-CME Innovation Theater
Time Zone: ET
2:30 PM – 2:45 PM ET
Break
2:30 PM – 2:45 PM ET
Break
Time Zone: ET
2:45 PM – 3:20 PM ET
Session 5: Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer
2:45 PM – 3:20 PM ET
Session 5: Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial CancerTime Zone: ETPresenter: – Washington University School of Medicine
Matthew Powell, MD (he/him/his) – Washington University School of Medicine ### 1929977###Presenter###Professor and Chief Division Gynecologic Oncology###Washington University School of Medicine###Presenter: – Washington University School of Medicine
### he/him/his3:20 PM – 3:30 PM ET
Live Q&A
3:20 PM – 3:30 PM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Speaker: – Washington University School of Medicine
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Matthew Powell, MD (he/him/his) – Washington University School of Medicine ### 1929977###Speaker###Professor and Chief Division Gynecologic Oncology###Washington University School of Medicine###Speaker: – Washington University School of Medicine
### he/him/his3:30 PM – 3:45 PM ET
Break
3:30 PM – 3:45 PM ET
Break
Time Zone: ET
3:45 PM – 4:20 PM ET
Session 6: Emerging Developments in Recurrent (2L and beyond) Endometrial Cancer
3:45 PM – 4:20 PM ET
Session 6: Emerging Developments in Recurrent (2L and beyond) Endometrial CancerTime Zone: ETPresenter: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Presenter###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Presenter: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### 4:20 PM – 4:30 PM ET
Live Q&A
4:20 PM – 4:30 PM ET
Live Q&ATime Zone: ETSpeaker: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Speaker###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Speaker: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### 4:30 PM – 4:45 PM ET
Break
4:30 PM – 4:45 PM ET
Break
Time Zone: ET
4:45 PM – 5:20 PM ET
Session 7: Updates in Molecular Testing and Front-Line Treatment in Ovarian Cancer
4:45 PM – 5:20 PM ET
Session 7: Updates in Molecular Testing and Front-Line Treatment in Ovarian CancerTime Zone: ETPresenter: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
Bradley Monk, MD – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute ### 1186886###Presenter###Gynecologic Oncologist###Director, Principal Investigator, Community Research Development, HonorHealth Research Institute###Presenter: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
### 5:20 PM – 5:30 PM ET
Live Q&A
5:20 PM – 5:30 PM ET
Live Q&ATime Zone: ETModerator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
Presenter: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
Kathleen N. Moore, MD, MS – Stephenson Cancer Center, University of Oklahoma Health Sciences Center ### 1186885###Moderator###Associate Director of Clinical Research###Stephenson Cancer Center, University of Oklahoma Health Sciences Center###Moderator: – Stephenson Cancer Center, University of Oklahoma Health Sciences Center
### @@@ Bradley Monk, MD – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute ### 1186886###Presenter###Gynecologic Oncologist###Director, Principal Investigator, Community Research Development, HonorHealth Research Institute###Presenter: – Director, Principal Investigator, Community Research Development, HonorHealth Research Institute
###
